| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |